(C5Me5); 55.17 (OMe); 9.01, 8.94 (C5Me5). IR (KBr): nC N = 1588
3e: yields: 56% (route A), 70% (routed B). Anal. Calc. for
C72H88F12Ir4N8O12S4: C 36.29, H 3.72, N 4.70. Found C 36.11,
H, 3.70, N 4.58%. 1H NMR (400 MHz, CD3OD, ppm): d 8.67 (s,
4H, HC N); 8.11 (s, 8H, pyrazine); 7.84 (s, 4H, Ph); 4.02 (s, 12H,
Me); 1.69 (s, 60H, C5Me5). 1H NMR (400 MHz, CDCl3, ppm): d
8.59 (s, 4H, HC N in isomer A); 8.48 (s, 4H, HC N in isomer B);
8.43 (s, 8H, pyrazine in isomer B); 8.12 (s, 8H, pyrazine in isomer
A); 4.06 (s, 12H, Me in isomer B); 3.87 (s, 12H, Me in isomer A);
1.73 (60H, C5Me5 in isomer A); 1.65 (60H, (60H, C5Me5 in isomer
cm-1.
Preparation of tetranuclear complexes 3a–3e and 3a¢–3c¢
Route A. Pyrazine (0.1 mmol) was added to a suspension
of [Cp*MCl2]2 (0.1 mmol, M = Ir, Rh) in CH3OH at room
temperature and stirred for 5 h. Ag(CF3SO3) (0.4 mmol) was added
to the resulting yellow precipitate and stirred for 2 h. NaOAc (0.6
mmol) and corresponding substrate L1–L5 (0.1 mmol) were added
and kept stirring for an additional 12 h. Solvent was removed in
vacuum, and the residue was extracted with CH2Cl2. Further pu-
rification by silica gel column chromatography (CH2Cl2–CH3OH =
9 : 1) afforded isomers of tetranuclear complexes as a red solids in
yields of 54–58%.
B). IR (KBr): nC = 1536 cm-1.
N
3a¢: yields: 54% (route A), 62% (route B). Anal. Calc. for
C92H96F12Rh4N8O12S4: C 48.60, H 4.26, N 4.93. Found: C 48.81, H
4.59, N 4.79%. 1H NMR (400 MHz, CD3OD, ppm): d 8.88 (d, 4H,
HC N); 8.25 (s, 8H, pyrazine); 8.20 (d, 4H, Ar–H); 7.48–7.53 (m,
12H, Ph); 7.21–7.33 (m, 8H, Ph); 1.60 (s, 60H, C5Me5). 1H NMR
(400 MHz, CDCl3, ppm): d 8.78 (s, 4H, HC N); 8.67 (s, 4H,
HC N); 8.54 (s, 8H, pyrazine); 8.25 (s, 8H, pyrazine); 7.30–7.12
(m, 40H, Ph); 1.51–1.48 (d, 120H, C5Me5). IR (KBr): nC N = 1556
cm-1.
Route B. Ag(CF3SO3) (51 mg, 0.2 mmol) was added to
a solution of the corresponding binuclear complex 1a–1e or
1a¢–1c¢ (0.1 mmol) in CH3OH (20 mL) at room temperature
and stirred for 3 h, followed by filtration to remove insoluble
materials. Pyrazine (0.1 mmol) was added to the filtrate and
stirred for 12 h. The solvent was removed, and the residue was
extracted with CH2Cl2. Further purification by silica gel column
chromatography (CH2Cl2–CH3OH = 9 : 1) afforded isomers of
tetranuclear complexes as a red solid in yields of 60–72%.
3b¢: yields: 53% (route A), 63% (route B). Anal. Calc. for
C96H104F12Rh4N8O16S4: C 48.17, H 4.38, N 4.68. Found: C 48.10,
1
H 4.30, N 4.53%. H NMR (400 MHz, CDCl3, ppm): d 8.63 (s,
4H, HC N); 8.41 (s, 8H, pyrazine); 8.11 (d, 4H, Ar–H); 7.36
(d, 8H, Ar–H); 7.11 (d, 8H, Ar–H); 3.93 (s, 12H, OCH3); 1.50 (s,
1
3a: yields: 56% (route A), 72% (route B). Anal. Calc. for
C92H96F12Ir4N8O12S4: C 42.00, H 3.68, N 4.26. Found: C 41.82,
H 3.63, N 4.09%. 1H NMR (400 MHz, CD3OD, ppm): d 8.86 (d,
4H, HC N); 8.29 (s, 8H, pyrazine); 8.24 (d, 4H, Ar–H); 7.49–
7.58 (m, 12H, Ph); 7.28–7.30 (m, 8H, Ph); 1.52 (s, 60H, C5Me5).
1H NMR (400 MHz, CDCl3, ppm): d 8.79 (s, 4H, HC N); 8.69
(s, 4H, HC N); 8.56 (s, 8H, pyrazine); 8.26 (s, 8H, pyrazine);
7, 50–7.01 (m, 40H, Ph); 1.56–1.51 (d, 120H, C5Me5). IR (KBr):
60H, C5Me5). H NMR (400 MHz, CDCl3, ppm): d 8.58 (s, 4H,
HC N); 8. 48 (s, 4H, HC N); 8.40 (d, 16H, pyrazine); 8.18–7.16
(m, 40H, Ar–H); 3.90–3.81 (d, 24H, OCH3); 1.57–1.56 (d, 120H,
C5Me5). IR (KBr): nC = 1556 cm-1.
N
3c¢: yields: 58% (route A), 60% (routed B). Anal. Calc. for
C96H104F12Rh4N8O12S4: C 49.49, H 4.50, N 4.81. Found: C 49.40,
1
H 4.72, N 4.76%. H NMR (400 MHz, CDCl3, ppm): d 8.69 (s,
4H, HC N); 8.40 (s, 8H, pyrazine); 8.25 (d, 4H, Ar–H); 7.28
nC = 1555 cm-1.
(d, 8H, Ar–H); 7.00 (d, 8H, Ar–H); 2.41 (s, 12H, CH3); 1.54 (s,
N
1
3b: yields: 58% (route A), 75% (routed B). Anal. Calc. for
60H, C5Me5). H NMR (400 MHz, CDCl3, ppm): d 8.60 (s, 4H,
C96H104F12Ir4N8O16S4: C 41.91, H 3.81, N 4.07. Found: C 41.78,
H 3.54, N 4.33%. H NMR (400 MHz, CDCl3, ppm): d 8.62 (s,
4H, HC N); 8.40 (s, 8H, pyrazine); 8.14 (d, 4H, Ar–H); 7.36
HC N); 8.41 (s, 4H, HC N); 8.40–8.35 (d, 16H, pyrazine); 8.18–
1
7.11 (m, 40H, Ar–H); 2.40–2.39 (d, 24H, OCH3); 1.56 (d, 120H,
C5Me5). IR (KBr): nC = 1531 cm-1.
N
(d, 8H, Ar–H); 7.14 (d, 8H, Ar–H); 3.91 (s, 12H, OCH3); 1.57
1
(s, 60H, C5Me5). H NMR (400 MHz, CDCl3, ppm): d 8.60 (s,
4H, HC N); 8. 51 (s, 4H, HC N); 8.47–8.44 (d, 16H, pyrazine);
Preparation of tetranuclear complexes 4a and 4b
8.20–7.11 (m, 40H, Ar–H); 3.90–3.82 (d, 24H, OCH3); 1.57–1.56
(d, 120H, C5Me5). IR (KBr): nC = 1556 cm-1.
Ag(CF3SO3) (0.2 mmol) was added to a solution of corresponding
binuclear complex 2a and 2b (0.1 mmol) in CH3OH (20 mL) at
room temperature and stirred for 3 h, followed by filtration to
remove insoluble materials. Pyrazine (0.1 mmol) was added to the
filtrate and stirred for 12 h. The solvent was removed and the
residue was extracted with CH2Cl2. Further purification by silica
gel column chromatography (CH2Cl2–CH3OH = 9 : 1) afforded
pure tetranuclear complexes as red solids in yields of 75–78%.
4a: Red, yield: 75%. Anal. Calc. for C92H96F12Ir4N8O12S4: C
42.00, H 3.68, N 4.26. Found: C 41.79, H 3.31, N 4.17%. 1H NMR
(400 MHz, CD3OD, ppm): d 8.56 (s, 4H, HC N); 8.44 (s, 8H,
pyrazine); 7.89 (m, 4H, Ar–H); 7.89 (m, 8H, Ar–H); 7.56 (d, 4H,
Ar–H); 7.37 (m, 4H, Ar–H); 7.00–7.05 (m, 4H, Ar–H); 1.29 (s,
N
3c: yields: 54% (route A), 63% (routed B). Anal. Calc. for
C96H104F12Ir4N8O12S4: C 42.91, H 3.90, N 4.17. Found: C 42.73,
1
H 3.71, N 4.26%. H NMR (400 MHz, CDCl3, ppm): d 8.69 (s,
4H, HC N); 8.43 (s, 8H, pyrazine); 8.28 (d, 4H, Ar–H); 7.39
(d, 8H, Ar–H); 7.06 (d, 8H, Ar–H); 2.42 (s, 12H, CH3); 1.54 (s,
1
60H, C5Me5). H NMR (400 MHz, CDCl3, ppm): d 8.63 (s, 4H,
HC N); 8.49 (s, 4H, HC N); 8.44–8.40 (d, 16H, pyrazine); 8.19–
7.10 (m, 40H, Ar–H); 2.41–2.39 (d, 24H, OCH3); 1.56 (d, 120H,
C5Me5). IR (KBr): nC = 1555 cm-1.
N
3d: yields: 54% (route A), 60% (routed B). Anal. Calc. for
C92H92Cl4F12Ir4N8O12S4: C 39.91, H 3.35, N 4.05. Found: C 39.65,
H 3.04, N 4.02%. 1H NMR (400 MHz, CD3OD, ppm): d 8.75 (s,
4H, HC N); 8.13–8.15 (m, 12H, pyrazine and Ar–H); 7.49 (d,
8H, Ar–H); 7.22 (d, 8H, Ar–H); 1.57 (s, 60H, C5Me5). 1H NMR
(400 MHz, CDCl3, ppm): d 8.55 (s, 4H, HC N); 8. 42 (s, 4H,
HC N); 8.13–7.13 (m, 56H, pyrazine and Ar–H); 1.59–1.56 (d,
1
60H, C5Me5). H NMR (400 MHz, CDCl3, ppm): d 8.60 (s, 4H,
HC N); 8.24 (s, 8H, pyrazine); 7.83–7.81 (d, 4H, Ph); 7.58–7.56
(d, 4H, Ph); 7.40–7.38 (d, 8H, Ph); 7.17–6.98 (m, 8H, Ph); 6.70–
6.67 (d, 8H, Ph); 1.26 (s, 60H, C5Me5). IR (KBr): nC = 1584
N
120H, C5Me5). IR (KBr): nC = 1551 cm-1.
cm-1.
N
This journal is
The Royal Society of Chemistry 2011
Dalton Trans., 2011, 40, 4982–4993 | 4991
©